Related posts
Weekly 52-Week Low (or 52-Week High): EMA-T, AGI-T, CMG-T, CIA-T and More 52-Week Highs and Lows (Mar 05-11)Weekly 52-Week Low (or 52-Week High): BB-T, AEM-T, DOO-T, TSU-T and More 52-Week Highs and Lows (Jan 29-Feb 04)Weekly 52-Week Low (or 52-Week High): BB-T, AEM-T, DOO-T, TSU-T and More 52-Week Highs and Lows (Jan 29-Feb 04)This summary was created by AI, based on 2 opinions in the last 12 months.
Curaleaf Holdings Inc. is facing significant challenges primarily due to the legal landscape surrounding marijuana in the United States. The company's products are hindered by federal laws that classify marijuana as illegal, preventing firms from deducting business expenses like traditional industries can. Additionally, there is concern about the oversupply of products in the market, further complicating profitability. As the landscape is currently unfavorable for cannabis businesses, particularly in the U.S. where rescheduling has not yet occurred, experts express doubt regarding the stock's long-term investment potential. While there may be a possibility for gains if U.S. legislation changes favorably in the future, investors are advised to stay cautious, as the current situation does not align with solid investment fundamentals.
US rescheduling hasn't happened. Off peak. Fits and starts when there's news. Entrenched opposition. US firms can't deduct expenses like a "legitimate" business, so can't turn a profit. Trader's dream, but not for long term.
He deals with 3- to 5-year money, holds it a long time, and rides the growth of the underlying business. Canadian marijuana space is at risk. US landscape is more fertile, better capitalized, better opportunities, and more upside, especially when the US legislation becomes law.
Curaleaf Holdings Inc is a OTC stock, trading under the symbol CURA-CSE on the (). It is usually referred to as or CURA-CSE
In the last year, 3 stock analysts published opinions about CURA-CSE. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Curaleaf Holdings Inc.
Curaleaf Holdings Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Curaleaf Holdings Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered Curaleaf Holdings Inc In the last year. It is a trending stock that is worth watching.
On , Curaleaf Holdings Inc (CURA-CSE) stock closed at a price of $.
Large issue with the company is legalizing the products(marijuana). Another worry is the over supply of products in the market. Federal laws against marijuana in USA make it hard to deal with expenses that are not deductible (100% tax rate). Could be a good investment if US legislation changes. In the meantime, would not recommend investing.